|
|
Why Is Aardvark Therapeutics Stock Sinking Monday?
|
|
|
|
HC Wainwright & Co. Downgrades Aardvark Therapeutics to Neutral
|
|
|
|
Morgan Stanley Downgrades Aardvark Therapeutics to Equal-Weight, Lowers Price Target to $7
|
|
|
|
Stifel Downgrades Aardvark Therapeutics to Hold, Lowers Price Target to $6
|
|
|
|
RBC Capital Downgrades Aardvark Therapeutics to Sector Perform, Lowers Price Target to $6
|
|
|
|
Stock Market Today: S&P 500, Dow Jones Futures Slide Amid War Against Iran— AMTD Digital, Aardvark, MongoDB In Focus
|
|
|
|
Why AMTD Digital Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
|
|
|
|
Aardvark Therapeutics shares are trading lower after the company announced it voluntarily paused the Phase 3 Hunger Elimination or Reduction Objective trial.
|
|
|
|
Trading Halt: Halt status updated at 4:30:00 PM ET: Quotation Resumption: News and Resumption Times
|
|
|
|
Aardvark Therapeutics Voluntarily Pauses Phase 3 HERO Trial Of ARD-101 In Prader-Willi Syndrome After Reversible Cardiac Findings At Supratherapeutic Doses; Delays Expected Q3 2026 Topline Data
|
|